Press Releases

Sign up for Email Alerts Press Release RSS

12/17/2018
Bristol-Myers Squibb and H3 Biomedicine Announce Research Collaboration to Advance Novel Therapeutics Leveraging H3’s RNA Splicing Platform
Term:R&D News
Language:English
12/17/2018
Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Sprycel (dasatinib) for Pediatric Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Term:Corporate/Financial News
Language:English
12/10/2018
Bristol-Myers Squibb and Vedanta Biosciences Announce a New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) and VE800 in Patients with Advanced or Metastatic Cancers
Term:R&D News
Language:English
12/06/2018
Bristol-Myers Squibb Announces Dividend Increase
Term:Corporate/Financial News
Language:English
12/05/2018
Bristol-Myers Squibb to Announce Results for Fourth Quarter 2018 on January 24
Term:Corporate/Financial News
Language:English
12/03/2018
Bristol-Myers Squibb to Transfer $3.8 billion in U.S. Pension Liabilities
Term:Corporate/Financial News
Language:English
11/29/2018
Bristol-Myers Squibb to Highlight New Data from Broad Oncology Portfolio at the 60th American Society of Hematology Annual Meeting
Term:Corporate/Financial News
Language:English
11/29/2018
Bristol-Myers Squibb to Take Part in Citi 2018 Global Healthcare Conference
Term:Corporate/Financial News
Language:English
11/26/2018
Bristol-Myers Squibb Announces CheckMate -451 Study Did Not Meet Primary Endpoint of Overall Survival with Opdivo Plus Yervoy Vs. Placebo as A Maintenance Therapy in Patients with Extensive-Stage Small Cell Lung Cancer After Completion of First-Line...
Term:Corporate/Financial News
Language:English
11/26/2018
Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to ReviveMed, Strand Therapeutics
Term:
Language:English

Business Wire NewsHQ^sm